isradipine has been researched along with Learning Disabilities in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
Learning Disabilities: Conditions characterized by a significant discrepancy between an individual's perceived level of intellect and their ability to acquire new language and other cognitive skills. These may result from organic or psychological conditions. Relatively common subtypes include DYSLEXIA, DYSCALCULIA, and DYSGRAPHIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gholamipour-Badie, H | 1 |
| Naderi, N | 1 |
| Khodagholi, F | 1 |
| Shaerzadeh, F | 1 |
| Motamedi, F | 1 |
1 other study available for isradipine and Learning Disabilities
| Article | Year |
|---|---|
L-type calcium channel blockade alleviates molecular and reversal spatial learning and memory alterations induced by entorhinal amyloid pathology in rats.
Topics: Amyloid beta-Peptides; Analysis of Variance; Animals; Area Under Curve; Calcium Channel Blockers; Ca | 2013 |